These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Cardiovascular risk reduction: what do recent trials with rosuvastatin tell us? Fabbri G; Maggioni AP Adv Ther; 2009 May; 26(5):469-87. PubMed ID: 19444394 [TBL] [Abstract][Full Text] [Related]
5. The heart of the matter: reducing CVD risk. Hayman LL; Kamau MW; Stuart-Shor EM Nurse Pract; 2009 May; 34(5):30-5. PubMed ID: 19390396 [No Abstract] [Full Text] [Related]
6. Understanding cholesterol and its role in heart disease. Evered A Nurs Times; 2007 Jan 9-15; 103(2):28-9. PubMed ID: 17278732 [TBL] [Abstract][Full Text] [Related]
7. Implications of LDL subclass B in patients at cardiovascular risk. Moredich C; Kark D; Keresztes P Nurse Pract; 2005 Jul; 30(7):16-8, 23, 26, passim; quiz 29-31. PubMed ID: 16021026 [No Abstract] [Full Text] [Related]
8. Managing the patient with hypertriglyceridemia: a practical approach for nurse practitioners. Rankin FM; Cohen JD J Am Acad Nurse Pract; 2008 Dec; 20 Suppl 2():1-14; quiz 15. PubMed ID: 19143900 [No Abstract] [Full Text] [Related]
10. The importance of managing cardiovascular risk in the treatment of hypertension: the role of ACE inhibitors and ARBs. Pierson CA; Epstein BJ; Roberts ME J Am Acad Nurse Pract; 2008 Nov; 20(11):529-38. PubMed ID: 19128336 [No Abstract] [Full Text] [Related]
11. The editor's roundtable: the JUPITER trial--initial results and clinical implications. Ridker PM; Friedewald VE; Davidson MH; Willerson JT; Roberts WC Am J Cardiol; 2009 May; 103(10):1417-25. PubMed ID: 19427439 [No Abstract] [Full Text] [Related]
12. Cholesterol, cholesterol-lowering agents/statins, and urologic disease: Part V--Statins versus aspirin for primary prevention, and the winner is...? Moyad MA; Merrick GS Urol Nurs; 2007 Apr; 27(2):166-8. PubMed ID: 17494461 [TBL] [Abstract][Full Text] [Related]
13. [Target levels for LDL cholesterol are put out of the running. Cholesterol should be lowered maximally in high cardiovascular risk]. Olsson AG Lakartidningen; 2011 Jun 1-14; 108(22-23):1240-3. PubMed ID: 21786498 [No Abstract] [Full Text] [Related]
14. Does nurse case management improve implementation of guidelines for cardiovascular disease risk reduction? Berra K J Cardiovasc Nurs; 2011; 26(2):145-67. PubMed ID: 21076315 [TBL] [Abstract][Full Text] [Related]
16. Identification of patients at risk of ischemic events for long-term secondary prevention. Brassard A J Am Acad Nurse Pract; 2009 Dec; 21(12):677-89. PubMed ID: 19958419 [TBL] [Abstract][Full Text] [Related]
18. Government cholesterol recommendations questioned. Levenson D Rep Med Guidel Outcomes Res; 2004 Oct; 15(20):9-10, 12. PubMed ID: 15505935 [No Abstract] [Full Text] [Related]
19. Guidelines update on the prevention of heart disease in women. Caboral MF; King WV; Goolsby MJ J Am Acad Nurse Pract; 2008 Apr; 20(4):191-3. PubMed ID: 18387015 [No Abstract] [Full Text] [Related]
20. Eligibility for lipid-lowering drug therapy in primary prevention: how do the Adult Treatment Panel II and Adult Treatment Panel III Guidelines compare? Gotto AM; Kuller LH Circulation; 2002 Jan; 105(2):136-9. PubMed ID: 11790688 [No Abstract] [Full Text] [Related] [Next] [New Search]